Welcome : Guest

Arrowhead Research Corporation (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Arrowhead Research Corporation, which is principally involved in Developing Novel Drugs to treat Intractable Diseases. Illustrated with 59 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-63765
Price: $2950
Company Type: Public
Pages: 61
Date: January 2016
Market Data Tables: 59

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Diabetes Drugs......2
Table 1: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......2
Table 2: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2014) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......3
Table 3: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......4
Monoclonal Antibodies (MABs)......5
Table 4: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......5
Liver Drugs......6
Table 5: Finished Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Antihypertensive Drugs, Digestive System Drugs, Liver Drugs and Others......6
Oncology Drugs......7
Table 6: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......7
Table 7: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......8
Table 8: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......9
Table 9: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......10
Speciality Drugs......11
Table 10: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......11
Table 11: Speciality Drug Sales by Therapeutic Category in the US (2014) - Percentage Market Share Breakdown by Value for Anticoagulants, Cancer, Growth Deficiency, Hepatitis C, HIV, Inflammatory Conditions, Multiple Sclerosis, Pulmonary Hypertension, Respiratory Conditions, Transplant and Others......12
Table 12: Speciality Pharmaceuticals Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......13
Hepatitis B Market......14
Table 13: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......14
Table 14: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......15
Table 15: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......16
Hepatitis C Market......17
Table 16: Hepatitis C Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno Modulator, Polymerase Inhibitor, Protease Inhibitors, and Others* (Includes Ribavirin)......17
Table 17: Hepatitis C Market by Genotype Worldwide (2015) - Percentage Share Breakdown by Value for Genotype 1, Genotype 2 and Others......18
Table 18: Hepatitis C Virus Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno-Modulator, Polymerase Inhibitor, Protease Inhibitors, Ribavirin, and Others......19
Table 19: Health Insurance for Hepatitis C Virus (HCV) by Type in the US (2015) - Percentage Market Share Breakdown by Value for Commercial, Dual (Medicare and Medicaid), Medicaid, Medicare (Non- Dual), Prison, Uninsured, and Veteran Affairs......20
Table 20: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2014) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......21
Table 21: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2014) - Percentage Market Share Breakdown for GT1, and Non-GT1......22
Table 22: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2014) - Percentage Market Share Breakdown for GT1, and Non-GT1......23
Table 23: Hepatitis C Virus Market by Patient Conditions in the US (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......24
Table 24: Hepatitis C Virus Market by Patient Conditions in Europe (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......25
Multiple Sclerosis Market......26
Table 25: Multiple Sclerosis Disease Occurrence by Type Worldwide (2014) - Percentage Breakdown by Volume for Begin MS, Primary Progressive MS, Relapsing-Remiting MS, and Secondary Progressive MS......26
Table 26: Multiple Sclerosis Patient Care Expenditure by Category Worldwide (2014) - Percentage Breakdown by Value for Adaptations, Ambulatory Care, Disease Modifying Drugs, Early Retirement, Hospital Inpatient Care, Informal Care, Prescription and OTC Drugs, Services, Sick-leave and Redused Working Time, and Tests......27
Table 27: No. of Tcelna (Imilecleucel-T) Secondary Progressive Multiple Sclerosis Patients by Category in the US (2014) - Percentage Breakdown for Primary Progressive MS Patients, Relapsing-Remitting MS Patients, and Secondary-Progressive MS Patients......28
Relapsing-Remitting Multiple Sclerosis Market......29
Table 28: Relapsing-Remitting Multiple Sclerosis (RRMS) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union (EU), US, Rest of World (RoW)......29
Non Hodgkin lymphoma Market......30
Table 29: Non Hodgkin lymphoma (NHL) Market by Category Worldwide (2014) - Percentage Share Breakdown by Volume for Burkitt Lymphoma-Burkitt Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Immunodeficiency-Associated Lymphoproliferative Disorders, Lymphoplasmacytic Lymphoma, Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Mediastinal (Thymic) Large B-Cell Lymphoma, Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma, Small Cell Lymphocytic Lymphoma-Chronic Lymphocytic Leukemia, T-Cell and Natural Killer (NK) -Cell Lymphoma, and Others......30
Parkinson's Disease Market......31
Table 30: Parkinson's Market by Type Worldwide (2015) - Percentage Breakdown by Volume for Mild, Moderate and Severe......31
Table 31: Population Affliected with Parkinson's by Age Group in the US (2015) - Percentage Share Breakdown for 65-69, 70-74, 75-79, 80-84 and 85+......32
Intravenous and Subcutaneous Immunoglobulin Market......33
Table 32: Intravenous Immunoglobulin (IVIG) Usage by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Hematology and Oncology, Immune Thrombocytopenic Purpura (ITP), Neurology, Pelvic Inflammatory Disease (PID), and Others......33
Table 33: Intravenous Immunoglobulin (IVIG) Market by Region Worldwide (2014) - Percentage Market Share Breakdown by Volume Sales for Australia, Canada, Europe (East & West) and New Zealand, US, Others (Excluding US (Including Japan))......34
Table 34: Market Shares of Leading Intravenous Immunoglobulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co., Ltd., Ningbo Boya Medical Equipment Co., Ltd., Ningbo Shuanglin Mould Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., Shuyang Group, Tonrol Biopharm Co., Ltd., and Others......35
Table 35: Intravenous and Subcutaneous Immunoglobulin (IVIG & SCIG) Market by Indication in the US (2014) - Percentage Share Breakdown by Volume for CIDP (Chronic Inflammatory Demyelinating Polyneuropathy), CLL (Chronic Lymphocytic leukaemia), ITP (Idiopathic Thrombocytopenic Purpura), MMN (Multifocal Motor Neuropathy), PID (Primary Immune Deficiency) and Others......36
Table 36: Intravenous Immunoglobulin (IVIG) Therapy by Disorders in the US (2014) - Percentage Market Share Breakdown by No. of Indications for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Chronic Lymphocytic Leukemia (CLL), Idiopathic Thrombocytopenic Purpura (ITP), Mismatch Negativity (MMN), Pelvic Inflammatory Disease (PID), and Others......37
Immunoassays Market......38
Table 37: Immunoassay Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Allergy, Autoimmunity, Bone and Mineral, Cardiac Markers, GI Stool Testing, Hepatitis and Retroviruses, Infectious Diseases, Oncology & Endocrinology, and Others......38
Plasma Products......39
Table 38: Plasma Market by Product Worldwide (2015) - Percentage Breakdown by Value for Albumin, Factor IX, Factor VIII, Hyperimmunes, Intravenous Immunoglobulin (IVIG), and Others......39
Table 39: Plasma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Coagulation Factor IX, Coagulation Factor VIII, Fibrinogen, Human Albumin, Intravenous Immunoglobulin (IVIG), Specific Immunoglobulin and Others......40
Table 40: Plasma Derivatives Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Albumin, Alpha-1 Proteinase Inhibitor (A1PI), Hyperimmune, Intravenous Immunoglobulin (IVIG), Plasma-Derived Factor VIII (PDFVIII) & Willebrand Factor (WFactor), Polymeric Immunoglobulin Receptor, and Others......41
Table 41: Plasma Derivatives Market by Region Worldwide (2014) - Percentage Share Breakdown by Value for Europe, North America, and Others......42
Table 42: Plasma Products Consumption by Type in China (2014) - Percentage Share Breakdown by Volume for Albumin, Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG)......43
Table 43: Plasma Products Consumption by Type in the US (2014) - Percentage Share Breakdown by Volume for Albumin, Factor IX (Plasma), Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG), and Others......44
Oncology Drugs......45
Table 44: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......45
Table 45: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......46
HBV/HCV Therapeutics......47
Table 46: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......47
Hepatitis A Drugs......48
Table 47: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......48
Table 48: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......49
Hepatitis B Drugs......50
Table 49: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......50
Table 50: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co., Ltd., Ningbo Boya Medical Equipment Co., Ltd., Shuyang Group, Tonrol Biopharm Co., Ltd., and Others......51
Table 51: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......52
Table 52: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......53
Hepatitis C Virus Drugs......54
Table 53: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......54
Intravenous Immunoglobulin Drugs......55
Table 54: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A., Octapharma AG and Others......55
Table 55: Market Shares of Leading Intravenous immunoglobulin (IVIG) Manufacturers in China (2015) - Percentage Breakdown by Value for Chengdu Institute of Biological Products Co., Ltd., China Biologic Products, Inc., Hualan Biological Engineering, Inc., Shanghai Institute of Biological Products Co., Ltd., Shanxi Kangbao Biological Product Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. and Others......56
Table 56: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in Europe (2015) - Percentage Breakdown by Value for Baxter International Inc., Biotest AG, CSL Ltd., Grifols, S.A (Incl.Talecris), Octapharma AG, and Others......57
Table 57: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Ltd., Grifols, S.A (Incl.Talecris), and Others......58
Influenza Vaccines......59
Table 58: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......59
Multiple Sclerosis Therapeutics......60
Table 59: Market Shares of Leading Multiple Sclerosis Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biogen Idec, Novartis AG, Sanofi S.A., and Others......60